BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 12228754)

  • 21. [Endosurgery in treatment of urinary bladder cancer in elderly patients].
    Alferov SM; Grishin MA; Emel'ianenko AV
    Khirurgiia (Mosk); 2010; (9):30-5. PubMed ID: 21164419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.
    Koie T; Ohyama C; Hosogoe S; Yamamoto H; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Yoneyama T; Tobisawa Y; Mori K
    Int Urol Nephrol; 2015 Sep; 47(9):1509-14. PubMed ID: 26149637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
    Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L
    J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical significance of radical cystectomy with extended lymphadenectomy].
    Liu XZ; Shen KH; Yan XD; Yu W; Guo YL; He Q; Xi ZJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Aug; 43(4):574-8. PubMed ID: 21844970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Early diagnostics of bladder cancer recurrence with fluorescence in situ hybridization method in the first 24 months after a transurethral resection of a bladder in old and elderly persons].
    Pushkin AS; Ryzhak GA
    Adv Gerontol; 2012; 25(4):745-8. PubMed ID: 23734524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bladder tumor resection: doing it right.
    Black P
    J Urol; 2014 Jun; 191(6):1646-7. PubMed ID: 24647080
    [No Abstract]   [Full Text] [Related]  

  • 27. Partial cystectomy.
    Sweeney P; Kursh ED; Resnick MI
    Urol Clin North Am; 1992 Nov; 19(4):701-11. PubMed ID: 1441027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrence and progression of T1G3 transitional cell carcinoma of the bladder treated with intravesical bacillus Calmette-Guérin.
    Günlüsoy B; Değirmenci T; Arslan M; Nergiz N; Minareci S; Ayder AR
    Urol Int; 2005; 75(2):107-13. PubMed ID: 16123562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variability in surgical quality in a phase III clinical trial of radical cystectomy in patients with organ-confined, node-negative urothelial carcinoma of the bladder.
    Mata DA; Groshen S; Von Rundstedt FC; Skinner DG; Stadler WM; Cote RJ; Stein JP; Lerner SP
    J Surg Oncol; 2015 Jun; 111(7):923-8. PubMed ID: 25873574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphadenectomy for bladder cancer: indications and controversies.
    Burkhard FC; Roth B; Zehnder P; Studer UE
    Urol Clin North Am; 2011 Nov; 38(4):397-405, v. PubMed ID: 22045171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.
    Stein JP; Cai J; Groshen S; Skinner DG
    J Urol; 2003 Jul; 170(1):35-41. PubMed ID: 12796639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Follow-up after surgical treatment of bladder cancer: a critical analysis of the literature.
    Soukup V; Babjuk M; Bellmunt J; Dalbagni G; Giannarini G; Hakenberg OW; Herr H; Lechevallier E; Ribal MJ
    Eur Urol; 2012 Aug; 62(2):290-302. PubMed ID: 22609313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of superficial bladder carcinoma: time to rethink the treatment strategies in the era of orthotopic neo-bladder.
    Singh PB; Kumar A; Das SK; Pandey AK; Sharma GK; Samir Swain HB; Trivedi S; Dwivedi US
    Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):881-5. PubMed ID: 20814125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
    Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
    Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Organ-sparing strategies in the management of invasive bladder cancer.
    Yafi FA; Cury FL; Kassouf W
    Expert Rev Anticancer Ther; 2009 Dec; 9(12):1765-75. PubMed ID: 19954288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Timing and outcomes for radical cystectomy in nonmuscle invasive bladder cancer.
    Zehnder P; Thalmann GN
    Curr Opin Urol; 2013 Sep; 23(5):423-8. PubMed ID: 23880740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radical cystectomy and lymphadenectomy for invasive bladder cancer: towards the evolution of an optimal surgical standard.
    Raj GV; Bochner BH
    Semin Oncol; 2007 Apr; 34(2):110-21. PubMed ID: 17382794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis and treatment of urethral recurrence after radical cystectomy in the male].
    Huguet J
    Actas Urol Esp; 2012 Jan; 36(1):42-7. PubMed ID: 21821317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrence-free survival after radical cystectomy of patients downstaged by transurethral resection.
    Nielsen ME; Bastian PJ; Palapattu GS; Trock BJ; Schoenberg MP; Chan T; Rogers CG
    Urology; 2007 Dec; 70(6):1091-5. PubMed ID: 18158024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.